PRDS DATA Tel: 185-1234-5678 页头:登录 | 页头:注册

Lasa Supergenerics Ltd.(BSE:LASA)

{{price.price}} INR
{{price.change}}%
{{price.high}} 1 0.5% -7.219
{{price.low}} 9 % 31
{{price.open}} 3.71% -37.96% 8
{{price.close}} 3.71 65338000% 472454692
11.14 -6.86 -30.83 -10.93
-62.28 -64.6 -89.07 -93.01
3.58 5.03 5.83 1
14161 50384 符号详情:1天涨跌率 3.71 -0.1
1.98
9 9 9 3387.9
3451.53 5308.33 18980.61 1.08
3.71 -2.96 -0.1 0
0.59 0.08 8 8
8 8 8 10
13 14 214 31
-2.95 -7.22 -147573000 -361684000
-48236000 178530000 65338000
-1.25 -2.95 -7.22 -101321000
1424481000 952905000
-22482000
66423000 563421000
6961000 2754000 6961000 7904000
123760000 178187000 157516000 157516000
73384000 722291000 538877692 70.39
-10.36
-37.96 12.53 6.86 -16.36
-49.19 -4.24 -10.63
Lasa Supergenerics Ltd. engages in the manufacture of veterinary preparations. It offers veterinary application programming interface products, animal feed ingredients, and reagents for therapeutic use. Its products include Fenbendazole, Toldimphos sodium, Cyromazine, Albendazole, Triclabendazole, Rafoxanide, and Ornidazole. The company was founded on March 11, 2016 and is headquartered in Mumbai, India.

-

Omkar Pravin Herlekar

2016

Mumbai

Health technology

Pharmaceuticals: major